<p>(A) In VGLUT1- labeled terminals there was no change in glutamate density with 6OHDA lesions. In 6OHDA-lesioned rats, STN lesions resulted in a decrease in glutamate particle density in VGLUT1-immunolabeled terminals (p<0.05), as did STN stimulation (p<0.01). 6OHDA-lesioned rats which underwent STN electrode placement alone did not show significant changes compared with 6OHDA alone. (B) Glutamate immuno-gold particle density in non-VGLUT1-immunolabeled terminals. There was no change in glutamate density in 6OHDA-lesioned rats in non-VGLUT1-immunolabeled, thalamostriatal terminals. There was a decrease in glutamate particle density with STN stimulation (p<0.02) as compared with controls, although only a trend to decrease (p<0.09) compared...
AbstractObjectivesVarious focal brain lesions are primarily caused by excessive glutamate release. A...
There is compelling evidence that glutamate can act as a cotransmitter in the mammalian brain. Inter...
<p>Percentages of VGLUT1-labeled terminals synapsing upon dendritic spines (A) and shafts (B) in the...
<p>Compared with control (A), in 6OHDA-lesioned rats, there were relatively more VGLUT-1 labeled ter...
Abnormalities of striatal glutamate neurotransmission may play a role in the pathophysiology of Park...
<p>(A) <b>Control</b>. Electron photomicrographs of VGLUT1-labeled (L-NT) and -unlabeled (UN-NT) ner...
<p><b>A, B</b>, Dot blots showing colloidal gold immunolabeling densities at high (A) or low (B) glu...
<p>Mean ± standard deviation of number of particles/µm<sup>2</sup>.</p>*<p>significantly different f...
Overactivity of glutamatergic neurotransmission in the basal ganglia is known to be closely related ...
Overactivity of the glutamatergic system is suggested to be closely related to the onset and pathoge...
Parkinson's disease is characterized by disturbed glutamatergic neurotransmission in the striatum. I...
The position of the caudal intralaminar nuclei within basal ganglia circuitry has largely been negle...
International audienceBACKGROUND: It has been suggested that glutamatergic system hyperactivity may ...
Biochemical and pharmacological experiments support glutamate (Glu) as a thalamocortical transmitter...
Striatal dopamine loss in Parkinson's disease is accompanied by a dysregulation of corticostriatal g...
AbstractObjectivesVarious focal brain lesions are primarily caused by excessive glutamate release. A...
There is compelling evidence that glutamate can act as a cotransmitter in the mammalian brain. Inter...
<p>Percentages of VGLUT1-labeled terminals synapsing upon dendritic spines (A) and shafts (B) in the...
<p>Compared with control (A), in 6OHDA-lesioned rats, there were relatively more VGLUT-1 labeled ter...
Abnormalities of striatal glutamate neurotransmission may play a role in the pathophysiology of Park...
<p>(A) <b>Control</b>. Electron photomicrographs of VGLUT1-labeled (L-NT) and -unlabeled (UN-NT) ner...
<p><b>A, B</b>, Dot blots showing colloidal gold immunolabeling densities at high (A) or low (B) glu...
<p>Mean ± standard deviation of number of particles/µm<sup>2</sup>.</p>*<p>significantly different f...
Overactivity of glutamatergic neurotransmission in the basal ganglia is known to be closely related ...
Overactivity of the glutamatergic system is suggested to be closely related to the onset and pathoge...
Parkinson's disease is characterized by disturbed glutamatergic neurotransmission in the striatum. I...
The position of the caudal intralaminar nuclei within basal ganglia circuitry has largely been negle...
International audienceBACKGROUND: It has been suggested that glutamatergic system hyperactivity may ...
Biochemical and pharmacological experiments support glutamate (Glu) as a thalamocortical transmitter...
Striatal dopamine loss in Parkinson's disease is accompanied by a dysregulation of corticostriatal g...
AbstractObjectivesVarious focal brain lesions are primarily caused by excessive glutamate release. A...
There is compelling evidence that glutamate can act as a cotransmitter in the mammalian brain. Inter...
<p>Percentages of VGLUT1-labeled terminals synapsing upon dendritic spines (A) and shafts (B) in the...